AbbVie Inc.ABBVNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-25.71%
↓ 298% vs avg
Percentile
P15
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
12.96%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -25.71% |
| Q3 2025 | 36.31% |
| Q2 2025 | 215.17% |
| Q1 2025 | -76.80% |
| Q4 2024 | 29.39% |
| Q3 2024 | 139.85% |
| Q2 2024 | -43.79% |
| Q1 2024 | -15.00% |
| Q4 2023 | -37.25% |
| Q3 2023 | 19.86% |
| Q2 2023 | 50.70% |
| Q1 2023 | -43.55% |
| Q4 2022 | -2.29% |
| Q3 2022 | 51.89% |
| Q2 2022 | 1.98% |
| Q1 2022 | -3.29% |
| Q4 2021 | -36.04% |
| Q3 2021 | 62.27% |
| Q2 2021 | 0.27% |
| Q1 2021 | 0.47% |
| Q4 2020 | -16.74% |
| Q3 2020 | 88.73% |
| Q2 2020 | -19.03% |
| Q1 2020 | 16.49% |
| Q4 2019 | -28.10% |
| Q3 2019 | 83.89% |
| Q2 2019 | -17.90% |
| Q1 2019 | -11.06% |
| Q4 2018 | -25.02% |
| Q3 2018 | 57.85% |
| Q2 2018 | 8.36% |
| Q1 2018 | 2.36% |
| Q4 2017 | -21.00% |
| Q3 2017 | 63.31% |
| Q2 2017 | -4.71% |
| Q1 2017 | 36.40% |
| Q4 2016 | 5.98% |
| Q3 2016 | -24.19% |
| Q2 2016 | -9.87% |
| Q1 2016 | 8.41% |